Belite Bio Adr Stock Price Patterns

BLTE Stock  USD 175.26  0.65  0.37%   
The RSI of Belite Bio's stock price is about 64 suggesting that the stock is rather overbought by investors at the present time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Belite, making its price go up or down.

Momentum 64

 Buy Extended

 
Oversold
 
Overbought
The successful prediction of Belite Bio's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Belite Bio and does not consider all of the tangible or intangible factors available from Belite Bio's fundamental data. We analyze noise-free headlines and recent hype associated with Belite Bio ADR, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Belite Bio's stock price prediction:
EPS Estimate Next Quarter
(0.49)
EPS Estimate Current Year
(2.16)
EPS Estimate Next Year
(1.24)
Wall Street Target Price
192.125
EPS Estimate Current Quarter
(0.49)
Using Belite Bio hype-based prediction, you can estimate the value of Belite Bio ADR from the perspective of Belite Bio response to recently generated media hype and the effects of current headlines on its competitors.

Belite Bio ADR Hype to Price Pattern

Investor biases related to Belite Bio's public news can be used to forecast risks associated with an investment in Belite. The trend in average sentiment can be used to explain how an investor holding Belite can time the market purely based on public headlines and social activities around Belite Bio ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Belite Bio's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Belite Bio.
The fear of missing out, i.e., FOMO, can cause potential investors in Belite Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Belite because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Belite Bio after-hype prediction price

    
  USD 180.84  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Belite Bio Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Belite Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
160.44164.41190.38
Details
5 Analysts
Consensus
LowTargetHigh
174.83192.12213.26
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.87-0.64-0.47
Details

Belite Bio After-Hype Price Density Analysis

As far as predicting the price of Belite Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Belite Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Belite Bio, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Belite Bio Estimiated After-Hype Price Volatility

In the context of predicting Belite Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Belite Bio's historical news coverage. Belite Bio's after-hype downside and upside margins for the prediction period are 155.76 and 184.81, respectively. We have considered Belite Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
175.26
155.76
Downside
180.84
After-hype Price
184.81
Upside
Belite Bio is very steady at this time. Analysis and calculation of next after-hype price of Belite Bio ADR is based on 3 months time horizon.

Belite Bio Stock Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Belite Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Belite Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Belite Bio, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.74 
3.94
  2.61 
  1.52 
8 Events / Month
7 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
175.26
180.84
4.49 
111.61  
Notes

Belite Bio Hype Timeline

Belite Bio ADR is currently traded for 175.26. The entity has historical hype elasticity of -2.61, and average elasticity to hype of competition of 1.52. Belite is anticipated to increase in value after the next headline, with the price projected to jump to 180.84 or above. The average volatility of media hype impact on the company the price is about 111.61%. The price growth on the next news is projected to be 4.49%, whereas the daily expected return is currently at 0.74%. The volatility of related hype on Belite Bio is about 191.91%, with the expected price after the next announcement by competition of 176.78. Belite Bio ADR currently holds about 48.7 M in cash with (29.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.96. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days.
Check out Belite Bio Basic Forecasting Models to cross-verify your projections.

Belite Bio Related Hype Analysis

Having access to credible news sources related to Belite Bio's direct competition is more important than ever and may enhance your ability to predict Belite Bio's future price movements. Getting to know how Belite Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Belite Bio may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
MIRMMirum Pharmaceuticals(0.05)4 per month 1.83  0.21  4.60 (3.68) 16.13 
LGNDLigand Pharmaceuticals Incorporated 1.69 8 per month 0.00 (0.12) 3.29 (3.06) 12.56 
ADMAADMA Biologics 0.07 10 per month 2.37  0.03  4.86 (4.24) 14.85 
PRAXPraxis Precision Medicines 18.18 10 per month 3.44  0.18  9.33 (5.67) 36.21 
ACADACADIA Pharmaceuticals 0.28 7 per month 1.97 (0.03) 3.31 (2.94) 12.09 
SLNOSoleno Therapeutics(1.20)11 per month 0.00 (0.11) 5.16 (4.39) 15.78 
DYNDyne Therapeutics(0.37)8 per month 0.00 (0.06) 7.01 (5.89) 26.40 
ARQTArcutis Biotherapeutics(0.64)15 per month 2.06  0.03  4.79 (3.34) 14.92 
VKTXViking Therapeutics 1.27 12 per month 0.00 (0.1) 7.49 (6.14) 22.96 
CRNXCrinetics Pharmaceuticals 1.30 11 per month 2.60  0.01  3.94 (5.06) 23.50 

Belite Bio Additional Predictive Modules

Most predictive techniques to examine Belite price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Belite using various technical indicators. When you analyze Belite charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Belite Bio Predictive Indicators

The successful prediction of Belite Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Belite Bio ADR, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Belite Bio based on analysis of Belite Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Belite Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Belite Bio's related companies.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Complementary Tools for Belite Stock analysis

When running Belite Bio's price analysis, check to measure Belite Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Belite Bio is operating at the current time. Most of Belite Bio's value examination focuses on studying past and present price action to predict the probability of Belite Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Belite Bio's price. Additionally, you may evaluate how the addition of Belite Bio to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios